跳到主要內容

臺灣博碩士論文加值系統

(3.238.225.8) 您好!臺灣時間:2022/08/09 00:22
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:陳冠鳴
研究生(外文):Kuan-Ming Chen
論文名稱:利用核磁共振光譜研究蛇毒心臟毒素的結構平衡及與磷酸衍生物的交互作用
論文名稱(外文):NMR Study of Cobra Cardiotoxin on Conformational Equilibrium and Its Interaction with Phosphate Derivatives
指導教授:吳文桂
指導教授(外文):Wen-guey Wu
學位類別:碩士
校院名稱:國立清華大學
系所名稱:生命科學系
學門:生命科學學門
學類:生物學類
論文種類:學術論文
論文出版年:2002
畢業學年度:90
語文別:英文
論文頁數:60
中文關鍵詞:核磁共振蛇毒心臟毒素結構平衡磷酸衍生物
外文關鍵詞:NMRCobra Cardiotoxinconformational equilibriumphosphate derivatives
相關次數:
  • 被引用被引用:0
  • 點閱點閱:279
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
心臟毒蛋白分子是個帶正電的生物巨分子,可以和帶負電荷的分子如磷酸、脂質、及醣胺素等有很強的交互作用,最近發現這些磷酸衍生物可以抑制由心臟毒蛋白分子在紅血球上引起的溶血現象,因此決定心臟毒蛋白與磷酸衍生物的結合態,可進一步了解心臟毒素的毒理作用機制。雖然心臟毒蛋白分子和去氧腺核三磷酸 (dATP) 在酸性溶液下的複合體結構已被解出,本研究發現在近生理條件下心臟毒蛋白分子和dATP的複合體結構與在酸性溶液下有明顯的差異。運用核磁共振及電腦模擬,發現在中性溶液下dATP結合在心臟毒蛋白分子的凸面而非先前運用NMR在酸性溶液下的凹面。心臟毒蛋白分子和dATP的結合模式在酸性與中性溶液下的確不一樣這個結論,藉由螢光實驗也得到證實。
另外,我們也發現心臟毒蛋白分子 (CTX A3)有兩種構形的平衡存在,在25℃時,其數量比約為14.3%。藉由改變溫度及加入帶負電的三磷酸來觀察此兩種構形的比例變化。結果顯示,當溫度由5℃升到45℃時,其比例由22%降到12.4%。而當在25℃時,逐漸加入2mM的三磷酸,其比例由14.3%升到了31.6%。利用熱力學分析,得到造成兩種構形的主要驅動力是來自於熵值的變化。而由兩種構形的化學位移差異,我們推論導致這兩種構形產生的機制可能是由於酪胺酸 (tyrosine) 苯環引起,但至今還沒有相對應到分子結構上發生變化之證據。

The major toxin (CTX A3) from Taiwan cobra (Naja atra) is a basic polypeptide capable of depolarizing cell membrane and causing lytic effect on many cells, including cardiomyocytes. It binds to several negatively charged ligands, such as phosphate derivatives, phospholipids and glycosaminoglycans. With unknown function, since phosphate derivatives compounds could inhibit the CTX-induced hemolysis, it is interesting to determine the binding mode to understand their structural and functional relationship. Although the complex structure of CTX A3 and dATP at acidic pH has been determined, it is not clear whether the interaction of CTX A3 and phosphate derivatives under physiological condition would be the same. Based on the NMR study and computer simulation, we found that the dATP bound to the convex side of CTX A3 at neutral pH, in sharp contrast to the concave side of CTX A2 as determined previously at low pH. The existence of two different binding modes of the dATP/CTX A3 complex at different pH was also proved by using fluorescence technique.
We also found that two forms of CTX coexisted as major (M) and minor (m) form as detected in the 2D 1H NMR spectra of CTX A3. At 25℃, the m/M ratio was about 14.3%. By changing temperature, the m/M ratio decreased from 22.0% at 5℃ to 12.4% at 45℃. With addition of 2 mM tripolyphosphate at 25℃, it increased from 14.3 to 31.6%. Thermodynamic analysis suggests that the main driving force is due to the change of entropy. In addition, the chemical shift difference between two conformations indicates the mechanism of conformational transition may be derived from the tyrosine ring but the evidence corresponding to the change of molecular structure is not found yet.

TABLE OF CONTENTS
I. INTRODUCTION…………………………..…………1
1.1 Snake Venom………………………………………….1
1.2 Structure of Cardiotoxin………………………………3
1.3 Origin of the Study on CTX A3 and
Phosphate Derivatives………………………………...4
1.4 Introduction to Phosphate Derivatives………………..5
1.5 Origin of Study on the Conformational
Equilibrium of CTX A3……………………………....5
II. MATERIALS AND METHODS…………..…….7
2.1 Phosphate Derivatives………………………………...7
2.2 Purification of Cardiotoxin……………………………7
2.3 Preparation of NMR Samples…………………………7
2.4 Protein Chemical Shift Variation Analysis……………8
2.5 Molecular Modeling of the Complex…………………8
2.6 Hemolysis Assay…………………………………...…9
2.7 Fluorescence Measurements…………………………..9
III. RESULTS AND DISCUSSION…………….........11
3.1 Hemolytic Result of CTX A3 After Treated
With Different Kind of Phosphate Derivatives….……11
3.2 NMR Chemical Shift Perturbation Caused by
Phosphate Derivatives………………………….……..11
3.3 Location of dATP Binding Site……………….………13
3.4 Conformation of dATP……………………….……….14
3.5 Experimental Evidence for the Presence of Two
Conformations in Equilibrium………………….…….14
3.6 Equilibrium Constant Between the Major and
Minor Conformation of CTX A3…………….……….15
3.7 Study the Major and Minor Conformations of
CTX A3 After Binding with Tripolyphosphate……....17
IV. CONCLUSION…………………...……………….....18
4.1 The Interaction of CTX A3 and Phosphate
Derivatives……………………………………………18

1. Lee, C. Y. (1979) Cardiovascular effect of snake venoms in: Snake Venoms. Handbook of Experimental Pharmacology, Vol 52, pp.546-590, Berlin: Springer-Verlag.
2. Wu, W. (1997) Diversity of Cobra Cardiotoxin. J. Toxicol-Toxin Reviews, 16, 115-134.
3. Chang, C. C. (1979) The action of snake venoms on nerve and muscle in: Snake Venoms. Handbook of Experimental Pharmacology, Vol 52, pp.309-375, Berlin: Springer-Verlag.
4. Rees, B., and Bilwes, A. (1993) Three-dimensional structures of neurotoxins and cardiotoxins. Chem. Res. Toxicol., 6(4), 387-406
5. Lee, C. Y., Chang, C. C., Chiu, P. J. S., Tseng, T. C., and Lee, S.Y. (1986) Naunyn-Schmiedebergs Arch. Pharmak. U. Exp. Path., 259, 360-374.
6. Lee, C. Y., Chang, C. C., Chiu, P. J. S., Tseng, T. C., and Lee, S. Y. (1968) Pharmacological properties of cardiotoxin isolated from Formasan cobra venom. Naunyn-Schmiedebergs Arch. Pharmacol., 12, 265-286.
7. Sun, J .J., and Walker, M. J. A. (1986) Action of cardiotoxin from the Southern Chinese cobra (Naja naja atra) on rat cardiac tissue. Toxico, 24, 233-245.
8. Harvey, A. L., and Hayashi, K. (1987) Depolarization of skeletal muscle cells in culture by a cardiotoxin-like basic polypeptide from the venom of the Taiwan cobra (Naja naja atra). Toxicon, 25, 681-684.
9. Boffa, M. C., Boffa, G. A., and Josso, F. (1969) Relationship between hemolytic action and lecithinase activity of Naja nigricollis venom. C R Acad Sci Hebd Seances Acad Sci D., 269(20), 2036-9.
10. Jaing, M. S., Fletcher, J. E., and Smith, L. A. (1989) Factors influencing the hemolysis of human erythrocytes by cardiotoxin from Naja naja kaouthia and Naja naja atra venoms and a Phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom. Toxicon, 27, 247-257.
11. Kini, R. M., Haar, N. C., and Evans, H. J. (1988) Non-enzymatic inhibitors of coagulation and platelet aggregation from Naja nigricollis venom are cardiotoxins. Biochem Biophys Res Commun., 150(3), 1012-6.
12. Warrell, D. A., Greenwood, B. M., Davidson,N.M., Ormerod,L.D., and Prentice,C.R. (1976) Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis). Q J Med., 45(177), 1-22.
13. Takechi, M., Tanaka, Y., and Hayashi, K. (1986) Binding of cardiotoxin analogue III from Formosan cobra venom to FL cells. FEBS Lett., 205, 143-146.
14. Chaim-Matyas A, and Ovadia M. (1987) Cytotoxic activity of various snake venoms on melanoma, B16F10 and chondrosarcoma. Life Sci., 40(16), 1601-7.
15. Borkow, G., Chaim-Matyas A., and Ovadia M. (1992) Binding of cytotoxin P4 from Naja nigricollis nigricollis to B16F10 melanoma and WEHI-3B leukemia cells. FEMS Microbiol Immunol., 5(1-3), 139-45.
16. Lee, C. Y. (1972) Chemistry and pharmacology of polypeptide toxins in snake venom. Ann. Rev. Pharmacol., 12, 265-286.
17. Harris, J. B., and A. L. Harvey. (1991) Pergamon, New York, pp. 259-302.
18. S. P. White, D. L. Scott, Z. Otwinowski, M. H. Gelb, and P. B. Sigler, (1990) Interfacial catalysis: the mechanism of phospholipase A2. Science, 250(4987), 1541-6.
19. Gerard Lambeau and Michel Lazdunski. (1999) Receptors for a growing family of secreted phospholipases A2. TiPS., Vol 20, 162-170.
20. Emmanuel Valentin and Gerard Lambeau. (2000) What can venom phospholipases A2 tell us about the functional diversity of mammalian secreted phospholipases A2? . Biochimie, 82, 815-831.
21. Elizabeth A. Capper, and Lisa A. Marshall. (2001) Mammalian phospholipases A2: mediators of inflammation, proliferation and apoptosis. Progress in Lipid Research., 40, 167-197.
22. Dufton, M. J., and Hider, R. C. (1988) Structure and pharmacology of elapid cytotoxins. Pharmacol. Ther., 36, 1-40.
23. Dufton, M. J., and Hider, R. C. (1991) The structure and pharmacology of elapid cytotoxins. Snake Venom, Harvey, A. L. ed., Pergamon Press, Inc., New York, pp.259-272.
24. Menez, A., Bontems, F., Roumestand, C., Gilquin, B., and Toma, F. (1992) Structural basis for functional diversity of animal toxins. Proc. Roy. Soc. Edinburgh., 90B, 83-163.
25. Rees, B., Bilwes, A., Samama, J. P., and Moras, D. (1990) Cardiotoxin VII4 from Naja mossambica mossambica. The refined crystal structure. J. Mol. Biol., 214, 281-297.
26. Bilwes, A., Rees, B., Moras, D., Menez, R. and Monez, A. (1994) X-ray structure at 1.55 A of toxin gamma, a cardiotoxin from Naja nigricollis venom. Crystal packing reveals a model for insertion into membranes. J. Mol. Biol., 239, 122-136.
27. Sun, Y. -J., Wu, W., Chiang, C.-M., Hsin, A.-Y., and Hsiao, C.-D. (1997) Crystal structure of cardiotoxin V from Taiwan cobra venom: pH-dependent conformational change and a novel membrane-binding motif identified in the three-fingered loops of P-type cardiotoxin. Biochemistry., 36, 2403-2413.
28. O’Connell, J. F., Bougis, P. E., and Wuthrich, K. (1993) Determination of the nuclear-magnetic-resonance solution structure of cardiotoxin CTX IIb from Naja mossambica mossambica. Eur. J. Biochem., 213, 891-900.
29. Gilquin, B., Roumestand, C., Zinn-Justin, S., Menez, A., and Toma, F. (1993) Refined three-dimensional solution structure of a snake cardiotoxin : Analysis of the Side-Chain Organization suggests the Existence of a possible phospholipid binding site. Bioplymers., 33, 1659-1675.
30. Singhal, A. K., Chien, K. -Y., Wu, W., and Rule, G. S. (1993) Solution structure of cardiotoxin V from Naja naja atra. Biochemistry., 32, 8036-8044.
31. Bhaskaran, R., Huang, C. -C., Chang, D. -K., and Yu, C. (1994) Cardiotoxin III from the Taiwan cobra (Naja naja atra). Determination of structure in solution and comparison with short neurotoxins. J. Mol. Biol., 235, 1291-1301.
32. Jahnke, W., Mierke, D. F., Beress, L., and Kessler, H. (1994) Structure of cobra cardiotoxin CTX I as derived from nuclear magnetic resonance spectroscopy and distance geometry calculations. J. Mol. Biol., 240, 445-458.
33. Bhaskaran, R., Huang, C. -C., Tsai, Y.-C., Jayaraman, G., Chang, D.-K., and Yu, C. (1994) Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. J. Biol. Chem., 269, 23500-23508.
34. Dementieva, D.V., Bocharov, E. V., and Arseniev, A. S. (1999) Two forms of cytotoxin II (cardiotoxin) from Naja naja oxiana in aqueous solution: spatial structures with tightly bound water molecules. Eur. J. Biochem., 263, 152-162.
35. Wu,W. (1998) Cobra cardiotoxin and Phospholipase A2 as GAG-binding toxins. TCM., 8(6), 270-277.
36. Bougis, P., Rochat, H., Pieroni, G., and Verger, R. (1982) A possible orientation change of cardiotoxin molecule during its interaction with phospholipid monolayer. Toxicon., 20, 187-190.
37. Dauplais, M., Neumann, J. M., Pinkasfeld, S. Menez, A., and Roumestand, C. (1995) An NMR study of the interaction of cardiotoxin gamma from Naja nigricollis with perdeuterated dodecylphosphocholine micelles. Eur. J. Biochem., 230, 213-220.
38. Picard, F., Pezolet, M., Bougis, P. E., and Auger, M. (1996) Model of interaction between a cardiotoxin and dimyristoylphosphatidic acid bilayers determined by solid-state 31P NMR spectroscopy. Biophys. J., 70, 1737-1744.
39. Sue, S. -C., Rajan, P. K., Chen, T. -S., Hsieh, C.-H., and Wu. W (1997) Action of Taiwan cobra cardiotoxin on membranes: binding modes of a beta-sheet polypeptide with phosphatidylcholine bilayers. Biochemistry., 36, 9826-9836.
40. Dubovskii, P. V., Dementieva, D.V., Bocharov, E. V., Utkin, Y. N., and Arseniev A. S. (2001) Membrane binding motif of the P-type cardiotoxin. J. Mol. Biol., 305, 137-149.
41. Chien KY, Chiang CM, Hseu YC, Vyas AA, Rule GS, Wu W. (1994) Two distinct types of cardiotoxin as revealed by the structure and activity relationship of their interaction with zwitterionic phospholipid dispersions. J Biol Chem., 269(20), 14473-83.
42. Jayaraman G, Krishnaswamy T, Kumar S, Yu C. (1999) Binding of nucleotide triphosphates to cardiotoxin analogue II from the Taiwan cobra venom (Naja naja atra). Elucidation of the structural interactions in the dATP-cardiotoxin analogue ii complex. J. Biol. Chem., 274(25), 17869-75.
43. Kuo JF, Raynor RL, Mazzei GJ, Schatzman RC, Turner RS, Kem WR. (1983) Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A-IV are potent and selective inhibitors of phospholipid-sensitive Ca2+-dependent protein kinase. FEBS Lett., 153(1), 183-6.
44. Chiou SH, Raynor RL, Zheng B, Chambers TC, Kuo JF. (1993) Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition. Biochemistry., 32(8), 2062-7.
45. Raynor RL, Zheng B, Kuo JF. (1991) Membrane interactions of amphiphilic polypeptides mastoparan, melittin, polymyxin B, and cardiotoxin. Differential inhibition of protein kinase C, Ca2+/calmodulin-dependent protein kinase II and synaptosomal membrane Na,K-ATPase, and Na+ pump and differentiation of HL60 cells. J Biol Chem., 266(5), 2753-8.
46. Zaheer, A., Noronha, S. H., Hospattanker, A. V. and Braganca, B. M. (1975) Inactivation of (Na-++K-+)-stimulated ATPase by a cytotoxic protein from cobra venom in relation to its lytic effects on cells. Biochim Biophys Acta., 394(2), 293-303.
47. Lin SY, Huang MC, Tseng WC, Lee CY. (1975) Comparative studies on the biological activities of cardiotoxin, melittin and prymnesin. Naunyn Schmiedebergs Arch Pharmacol., 287(4), 349-58.
48. Reginald H. Garrett, Charles M. Grisham (1999) Biochemistry, Saunders College Publishing, pp.50-52
49. Christopher K. Mathews, K.E. van Holde, Kevin G. Ahern (2000) Biochemistry, Addison Wesley Longman Inc., pp.73-78.
50. Sue, S. -C., Harold, J., Brisson, J.-R., Wu, W.-G. (2001) Dynamic characterization of the water binding loop in the P-type cardiotoxin: implication for the role of the bound water molecule. Biochemistry., 40, 12782.
51. Sue SC, Brisson JR, Chang SC, Huang WN, Lee SC, Jarrell HC, Wu W. (2001) Structures of heparin-derived disaccharide bound to cobra cardiotoxins: context-dependent conformational change of heparin upon binding to the rigid core of the three-fingered toxin. Biochemistry., 40(35), 10436-46.
52. Bax, A., and Davis, D. G. (1985) J. Magn. Reson., 65, 355-360.
53. Piotto, M., Saudek, V., and Sklendar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol.NMR., 2, 661-665.
54. H.V. R. Osorio, E. Castro, and Leo P. Vernon, (1989) Emolytic activity of thionin from Pyrularia pubera nuts and snake venom toxins of Naja naja species: Pyrularia thionin and snake venom cardiotoxin compete for the same membrane site. Toxicon., Vol. 27(5), 511-517.
55. Chien, K. -Y., Chiang, C. -M., Hseu, Y. -C., Vyas, A. A., Rule, G. S., and Wu. W. (1994) Two distinct types of cardiotoxin as revealed by the structure and activity relationship of their interaction with zwitterionic phospholipid dispersions. J. Biol. Chem., 269, 14473-14483.
56. Garin, J., Viginais, P. V., Gronenborn, A. M., Clore, G. M., Gao, Z., and Bauerlein, E. (1988) 1H-NMR studies on nucleotide binding to the catalytic sites of bovine mitochondrial F1-ATPase. FEBS Lett., 242(1), 178-82.
57. Otting G, Liepinsh E, Wuthrich K. (1993) Disulfide bond isomerization in BPTI and BPTI(G36S): an NMR study of correlated mobility in proteins. Biochemistry, 32(14), 3571-82.
58. Sorensen MD, Kristensen SM, Bjorn S, Norris K, Olsen O, Led JJ. (1996) Elucidation of the origin of multiple conformations of the human alpha 3-chain type VI collagen C-terminal Kunitz domain: the reorientation of the Trp21 ring. J. Biomol. NMR, 8(4), 391-403.
59. John Cavanagh, Wayne J. Fairbrother, Arthur G. Palmer III, Nicholas J. Skelton. (1996) Protein NMR Spectroscopy, Academic Press, pp. 290-300.
60. H. M. McConnell, J. Chem. Phys. (1958) 28, 430-431.
61. R. R. Ernst, G. Bidenhausen, and A. Wokaun, (1987) Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Clarendon Press, Oxford, pp. 1-610.
62. Grathwohl, C., & Wuthrich, K. (1981) Biopolymers, 20,2623-2633
63. Dementieva DV, Bocharov EV, Arseniev AS. (1999) Two forms of cytotoxin II (cardiotoxin) from Naja naja oxiana in aqueous solution: spatial structures with tightly bound water molecules. Eur. J. Biochem., 263(1), 152-62.
64. Campbell AP, Bautista DL, Tripet B, Wong WY, Irvin RT, Hodges RS, Sykes BD. (1997) Solution secondary structure of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK: A heteronuclear multidimensional NMR study. Biochemistry, 36(42), 12791-801.
65. Kordel J, Forsen S, Drakenberg T, Chazin WJ. (1990) The rate and structural consequences of proline cis-trans isomerization in calbindin D9k: NMR studies of the minor (cis-Pro43) isoform and the Pro43Gly mutant. Biochemistry, 29(18), 4400-9.
66. Martins JC, Enassar M, Willem R, Wieruzeski JM, Lippens G, Wodak SJ. (2001) Solution structure of the main alpha-amylase inhibitor from amaranth seeds. Eur. J. Biochem., 268(8), 2379-89.
67. Gooley PR, MacKenzie NE. (1990) Pro---Ala-35 Rhodobacter capsulatus cytochrome c2 shows dynamic not structural differences. A 1H and 15N NMR study. FEBS Lett., 260(2), 225-8.
68. Groth M, Malicka J, Rodziewicz- Motowidlo S, Czaplewski C, Klaudel L, Wiczk W, Liwo A. (2001) Determination of conformational equilibrium of peptides in solution by NMR spectroscopy and theoretical conformational analysis: application to the calibration of mean-field solvation models. Biopolymers, 60(2), 79-95.
69. Adjadj E, Naudat V, Quiniou E, Wouters D, Sautiere P, Craescu CT. (1997) Solution structure of Lqh-8/6, a toxin-like peptide from a scorpion venom--structural heterogeneity induced by proline cis/trans isomerization. Eur. J. Biochem., 246(1), 218-27.
70. Nedelkov D, O'Keefe MP, Chapman TL, Bieber AL. (1997) The role of Pro20 in the isomerization of myotoxin a from Crotalus viridis viridis: folding and structural characterization of synthetic myotoxin a and its Pro20Gly homolog. Biochem. Biophys. Res. Commun., 241(2), 525-9.
71. Wuthrich, K. (1976) NMR in Biological Research: Peptide and Proteins, North Holland, Amsterdam.
72. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids, Wile New York.
73. Nall BT, Zuniga EH. (1990) Rates and energetics of tyrosine ring flips in yeast iso-2-cytochrome c. Biochemistry, 29(33), 7576-84.
74. Sorensen MD, Kristensen SM, Bjorn S, Norris K, Olsen O, Led JJ. (1996) Elucidation of the origin of multiple conformations of the human alpha 3-chain type VI collagen C-terminal Kunitz domain: the reorientation of the Trp21 ring. J. Biomol. NMR, 8(4), 391-403.
75. Hansson H, Mattsson PT, Allard P, Haapaniemi P, Vihinen M, Smith CI, Hard T. (1998) Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry, 37(9), 2912-24.
76. Whittaker SB, Czisch M, Wechselberger R, Kaptein R, Hemmings AM, James R, Kleanthous C, Moore GR. (2000) Slow conformational dynamics of an endonuclease persist in its complex with its natural protein inhibitor. Protein Sci., 9(4), 713-20.
77. Donzel, B., Kamber, B., Wuthrich, K., & Schwyzer, R. (1972) Helv. Chem. Soc., 112, 2574-2577.
78. Jung G, Ottnad M. (1974) Temperature-induced change in helicity of the inherently dissymmetrical disulfide group in cyclocystine. Angew Chem. Int. Ed. Engl., 13 (12), 818-9.
79. Sorensen MD, Bjorn S, Norris K, Olsen O, Petersen L, James TL, Led JJ. (1997) Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain. Biochemistry, 36(34), 10439-50.
80. Barbar E, Hare M, Daragan V, Barany G, Woodward C. (1998) Dynamics of the conformational ensemble of partially folded bovine pancreatic trypsin inhibitor. Biochemistry, 37(21), 7822-33.
81. Li YC, Montelione GT. (1995) Human type-alpha transforming growth factor undergoes slow conformational exchange between multiple backbone conformations as characterized by nitrogen-15 relaxation measurements. Biochemistry, 34(8), 2408-23.
82. McInnes C, Kay CM, Hodges RS, Sykes BD. (1994) Conformational differences between cis and trans proline isomers of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa as studied by 1H-NMR. Biopolymers, 34(9), 1221-30.
83. J. Jeener, B. H. Meier, P. Bachmann, and R. R. Ernst (1979) Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys., 71(11), 4546-4553.
84. J. Schotland, and J. S. Leigh (1983) Exact solutions of the Bloch equations with n-site chemical exchange. J. Magn. Reson., 51, 48-55.
85. Anil Kumar, Gerhard Wagner, Richard R. Ernst, and Kurt Wuthrich (1981) Buildup rates of the Nuclear Overhauser Effect measured by two-dimensional proton magnetic resonance spectroscopy: Implications for studies of protein conformation. J. Am. Chem. Soc., 103, 3654-3658.
86. Henrik Gesmar, and Jens J. Led (1986) Optimizing the multisite magnetization-transfer experiment. J. Magn. Reson., 68, 95-101.
87. Waelder SF, Redfield AG. (1977) Nuclear magnetic resonance studies of exchangeable protons. II. The solvent exchange rate of the indole nitrogen proton of tryptophan derivatives. Biopolymers., 16(3), 623-9.
88. Krishna NR, Huang DH, Glickson JD, Rowan R 3rd, Walter R. (1979) Amide hydrogen exchange rates of peptides in H2O solution by 1H nuclear magnetic resonance transfer of solvent saturation method. Conformations of oxytocin and lysine vasopressin in aqueous solution. Bio0phys. J., 26(3), 345-66
89. Alger JR, Shulman RG. (1984) NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer. Q. Rev. Biophys., 17(1), 83-124.
90. K.Ugurbil, R. G. Shulman, and T. R. Brown (1979) Biological application of magnetic resonance. Academic Press, New York.
pp.537-589.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top